Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Fund Letter | Arman Gökgöl-Kline, John Harris, Trevor MagyarSequoia Fund | Align Technology, Inc. $ALGN• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Sequoia Fund 2025 Q4 (ALGN) Align Technology, Inc. (“Align”) is the company behind the Invisalign clear aligner orthodontic system. After years of... | BULL | View Pitch → |
| Jan 29, 2026 | Fund Letter | David M. PoppeGiverny Capital Asset Management | Align Technology, Inc. $ALGN• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Giverny Capital Asset Management 2025 Q4 (ALGN) Align Technology struggled in 2025 as orthodontic demand softened amid consumer pressure and increased competition at the low end of the market. Despite these headwinds,... | BULL | View Pitch → |
| Nov 28, 2025 | Fund Letter | ArrowMark Colorado Holdings, LLCMeridian Growth Fund | Align Technology, Inc. $ALGN• NASDAQ | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Meridian Growth Fund 2025 Q3 (ALGN) Align Technology, Inc. is a global leader in dental technology and the maker of Invisalign clear aligners. We were initially... | BEAR | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.